| Design and biological evaluation of lipoprotein-based donepezil nanocarrier for enhanced brain uptake through oral delivery KV Krishna, G Wadhwa, A Alexander, N Kanojia, RN Saha, R Kukreti, ... ACS chemical neuroscience 10 (9), 4124-4135, 2019 | 65 | 2019 |
| Multidrug efflux transporter ABCG2: expression and regulation S Kukal, D Guin, C Rawat, S Bora, MK Mishra, P Sharma, PR Paul, ... Cellular and Molecular Life Sciences, 1-53, 2021 | 60 | 2021 |
| Effect of oxidative stress on ABC transporters: contribution to epilepsy pharmacoresistance GK Grewal, S Kukal, N Kanojia, L Saso, S Kukreti, R Kukreti Molecules 22 (3), 365, 2017 | 56 | 2017 |
| In vitro assessment of the effect of antiepileptic drugs on expression and function of ABC transporters and their interactions with ABCC2 GK Grewal, S Kukal, N Kanojia, K Madan, L Saso, R Kukreti Molecules 22 (10), 1484, 2017 | 28 | 2017 |
| Genetic contribution of CYP1A1 variant on treatment outcome in epilepsy patients: a functional and interethnic perspective P Talwar, N Kanojia, S Mahendru, R Baghel, S Grover, G Arora, ... The pharmacogenomics journal 17 (3), 242-251, 2017 | 23 | 2017 |
| Evaluation of genetic association of neurodevelopment and neuroimmunological genes with antipsychotic treatment response in schizophrenia in Indian populations A Jajodia, H Kaur, K Kumari, N Kanojia, M Gupta, R Baghel, M Sood, ... Molecular genetics & genomic medicine 4 (1), 18-27, 2016 | 23 | 2016 |
| Systems approach to identify common genes and pathways associated with response to selective serotonin reuptake inhibitors and major depression risk A Srivastava, P Singh, H Gupta, H Kaur, N Kanojia, D Guin, M Sood, ... International journal of molecular sciences 20 (8), 1993, 2019 | 21 | 2019 |
| Natural product-based pharmacological studies for neurological disorders V Puri, N Kanojia, A Sharma, K Huanbutta, D Dheer, T Sangnim Frontiers in Pharmacology 13, 1011740, 2022 | 18 | 2022 |
| Exploring the Carbamazepine Interaction with Human Pregnane X Receptor and Effect on ABCC2 Using in Vitro and in Silico Approach GK Grewal, KD Singh, N Kanojia, C Rawat, S Kukal, A Jajodia, A Singhal, ... Pharmaceutical research 34, 1444-1458, 2017 | 11 | 2017 |
| Lipid mediated brain disorders: a perspective A Singh, S Kukal, N Kanojia, M Singh, L Saso, S Kukreti, R Kukreti Prostaglandins & Other Lipid Mediators 167, 106737, 2023 | 5 | 2023 |
| Valproic acid-induced upregulation of multidrug efflux transporter ABCG2/BCRP via PPARα-dependent mechanism in human brain endothelial cells S Kukal, S Bora, N Kanojia, P Singh, PR Paul, C Rawat, S Sagar, ... Molecular Pharmacology 103 (3), 145-157, 2023 | 4 | 2023 |
| Human genetic factors associated with pneumonia risk, a cue for COVID-19 susceptibility D Guin, S Yadav, P Singh, P Singh, S Thakran, S Kukal, N Kanojia, ... Infection, Genetics and Evolution 102, 105299, 2022 | 4 | 2022 |
| Genic-intergenic polymorphisms of CYP1A genes and their clinical impact S Kukal, S Thakran, N Kanojia, S Yadav, MK Mishra, D Guin, P Singh, ... Gene 857, 147171, 2023 | 3 | 2023 |
| Human genetic factors associated with pneumonia susceptibility, a cue for COVID-19 mortality D Guin, S Yadav, P Singh, P Singh, S Thakran, S Kukal, N Kanojia, ... medRxiv, 2021.06. 03.21258106, 2021 | | 2021 |
| Chapter 56: A molecular approach to understand the association of genetic variations with disease and drug response. NCRK Ankit Srivastava, Chitra Rawat, Neha Kanojia, Gurpreet Kaur Grewal ... Progress in MEDICINE (Harnessing current knowledge to clinical practice) 29 …, 2015 | | 2015 |
Dr Gurpreet Kaur GrewalLovely Professional University, Jalandhar在 lpu.co.in 的电子邮件经过验证
